Monoclonal antibodies can be defined as an antibody produced by a single clone of cells; they antibodies can be produced in large quantities in the laboratory. They can be used to carry drugs, toxins, or radioactive substances straight to cancer cells. Monoclonal antibodies have been showing promising results in the management of chronic diseases such as cancers and rheumatoid arthritis.
Growing demand for biosimilars and increasing investments in the development of biosimilar products are the major factors driving the market for monoclonal antibodies. However increasing awareness about alternate methods to purify monoclonal antibodies is expected to hamper the Protein A Resins market. High cost of the Protein A resin is also a major factor hindering the growth of the market.
Protein A Resins Market was worth USD 454.42 million in 2018 and estimated to be growing at a CAGR of 8.2%, to reach USD 673.9 million by 2023. The market is showcasing evident potential in the mentioned forecasting period. Increasing research on monoclonal antibodies is expected to drive sales of Protein A resins over the forecast period.
Protein A resin market is segmented by product type, application, matrix type and end user. On the basis if product the market is further sub-segmented into Natural Protein A Resin and Recombinant Protein A Resin. Recombinant Protein A segment is estimated to be the fastest growing within this segment. By application protein A resin market is segmented into Immunoprecipitation and Antibody Purification. In the application segment immune precipitation is estimated to be the fastest growing. Based on Matrix type Protein A Resin market is segmented into Glass or Silica, Agarose and Organic Polymer. Among the matrix type agarose accounts for the largest share and is estimated to continue its strong hold during the forecast period. By end user market is segmented into Biopharmaceutical Manufacturers, Clinical Research Laboratories and Academic Institutions
On the basis of geography Protein A resin market is analysed under various regions namely North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa. North America is the largest market for Protein A resin accounting for a share of approximately 37% due to large number investments in the development of monoclonal antibodies followed by Europe. Asia Pacific region is estimated to be the fastest growing region with a Compound Annual Growth Rate of XX% owing to large number of untapped markets and growing awareness about the developments in the market
Major Players in the market are entering into strategic agreements to develop raw materials required manufacture Protein A resins. Some of the key companies covered in the report are GE Healthcare, Repligen Corporation, Novasep, Tosoh Bioscience, GenScript, Thermo Fisher Scientific, EMD Millipore and Expedeon Ltd.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Product Type
5.1.1 Natural Protein A Resin
5.1.2 Recombinant Protein A Resin
5.2 By Application
5.2.1 Immunoprecipitation
5.2.2 Antibody Purification
5.3 By End Users
5.3.1 Biopharmaceutical Manufacturers
5.3.2 Clinical Research Laboratories
5.3.3 Academic Institutes
5.4 By Matrix Type
5.4.1 Glass or Silica
5.4.2 Agarose
5.4.3 Organic Polymer
6. Geographical Analysis
6.1 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.2 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
6.3 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 South Korea
6.4 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Mexico
6.4.4 Rest of Latin America
6.5 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 GE Healthcare
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Thermo Fisher Scientific
8.3 Repligen
8.4 Tosoh Bioscience
8.5 EMD Millipore
8.6 Novasep
8.7 GenScript
8.8 Expedeon Ltd
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
